Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Corrodi

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Acta Pharmaceutica Suecica|February 1, 1970
Dopamine beta-hydroxylase inhibitors. The preparation and the dopamine beta-hydroxylase inhibitory activity of some compounds related to dithiocarbamic acid and thiuramdisulfideL Florvall, H Corrodi
Acta Pharmaceutica Suecica|November 1, 1970
Cardiac stimulant 1-(hydroxyphenoxy)-3-isopropylamino-2-propanolsB Ablad, M Brogård, H Corrodi
Acta Pharmacologica Et Toxicologica|January 1, 1970
Renal lesions induced by alpha-methyltyrosine methylester and alpha-methyltyrosineG Magnusson, H Corrodi, E Hansson
Brain Research|August 25, 1972
Interaction between cholinergic and catecholaminergic neurones in rat brainH Corrodi, K Fuxe, P Lidbrink
The Journal of Pharmacy and Pharmacology|February 1, 1972
Effects of caffeine on central monoamine neuronsH Corrodi, K Fuxe, G Jonsson
The Journal of Pharmacy and Pharmacology|December 1, 1971
Evidence for a new type of dopamine receptor stimulating agentH Corrodi, K Fuxe, U Ungerstedt
European Journal of Pharmacology|April 1, 1974
Benzodiazepines and barbiturates: turnover changes in central 5-hydroxytryptamine pathwaysP Lidbrink, H Corrodi, K Fuxe
The Journal of Pharmacy and Pharmacology|March 1, 1972
Effect of neuroleptic drugs on central catecholamine turnover assessed using tyrosine- and dopamine- -hydroxylase inhibitorsN E Andén, H Corrodi, K Fuxe
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1971
Hallucinogenic drugs of the indolealkylamine type and central monoamine neuronsN E Andén, H Corrodi, K Fuxe
European Journal of Pharmacology|January 1, 1972
The effect of psychotomimetic glycolate esters on central monoamine neuronsN E Andén, H Corrodi, K Fuxe
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Acta Pharmaceutica Suecica|February 1, 1970
Dopamine beta-hydroxylase inhibitors. The preparation and the dopamine beta-hydroxylase inhibitory activity of some compounds related to dithiocarbamic acid and thiuramdisulfideL Florvall, H Corrodi
Acta Pharmaceutica Suecica|November 1, 1970
Cardiac stimulant 1-(hydroxyphenoxy)-3-isopropylamino-2-propanolsB Ablad, M Brogård, H Corrodi
Acta Pharmacologica Et Toxicologica|January 1, 1970
Renal lesions induced by alpha-methyltyrosine methylester and alpha-methyltyrosineG Magnusson, H Corrodi, E Hansson
Brain Research|August 25, 1972
Interaction between cholinergic and catecholaminergic neurones in rat brainH Corrodi, K Fuxe, P Lidbrink
The Journal of Pharmacy and Pharmacology|February 1, 1972
Effects of caffeine on central monoamine neuronsH Corrodi, K Fuxe, G Jonsson
The Journal of Pharmacy and Pharmacology|December 1, 1971
Evidence for a new type of dopamine receptor stimulating agentH Corrodi, K Fuxe, U Ungerstedt
European Journal of Pharmacology|April 1, 1974
Benzodiazepines and barbiturates: turnover changes in central 5-hydroxytryptamine pathwaysP Lidbrink, H Corrodi, K Fuxe
The Journal of Pharmacy and Pharmacology|March 1, 1972
Effect of neuroleptic drugs on central catecholamine turnover assessed using tyrosine- and dopamine- -hydroxylase inhibitorsN E Andén, H Corrodi, K Fuxe
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1971
Hallucinogenic drugs of the indolealkylamine type and central monoamine neuronsN E Andén, H Corrodi, K Fuxe
European Journal of Pharmacology|January 1, 1972
The effect of psychotomimetic glycolate esters on central monoamine neuronsN E Andén, H Corrodi, K Fuxe
Pageof 3